Results 11 to 20 of about 1,277,493 (295)

Das Epstein-Barr-Virus ( = Epstein-Barr virus) [PDF]

, 1993
Epstein-Barr virus is an ubiquitous humanpathogenic herpesvirus. It has been identified as the etiologic agent of infectious mononucleosis. In addition it is associated with the cancers nasopharyngeal carcinoma and Burkitt's lymphoma. Like other herpesviruses it infects cells in a lytic way or it persists in a latent state.
Niller, H. H., Wolf, Hans J.
core   +4 more sources

Resurrecting Epstein–Barr Virus

Pathogens, 2022
One of the Editor’s choice articles in 2021 published in Pathogens was an early assessment of the role of Epstein–Barr virus (EBV) reactivation in the pathogenesis of long-term symptoms associated with COVID-19 [...]
Roberto Paganelli
doaj   +3 more sources

The immunology of Epstein–Barr virus infection [PDF]

Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 2001
Epstein–Barr virus is a classic example of a persistent human virus that has caught the imagination of immunologists, virologists and oncologists because of the juxtaposition of a number of important properties. First, the ability of the virus to immortalize B lymphocytes in vitro has ...
Moss, Denis J., Burrows, Scott R., Silins, Sharon L., Misko, Ihor, Khanna, Rajiv   +4 more
openaire   +6 more sources

EPSTEIN-BARR VIRUS VACCINES [PDF]

Clinical & Translational Immunology, 2015
Epstein–Barr virus (EBV) is the primary cause of infectious mononucleosis (IM) and is associated with epithelial cell malignancies such as nasopharyngeal carcinoma and gastric carcinoma, as well as lymphoid malignancies including Hodgkin lymphoma, Burkitt lymphoma, non‐Hodgkin lymphoma and post‐transplant lymphoproliferative disorder.
KANEKIYO MASARU, NABEL GARY J, COHEN JEFFREY, BU WEI   +3 more
openaire   +10 more sources

Dynamic early biomarkers predict outcomes in pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. [PDF]

Pediatr Investig
This study elucidates the critical pathogenic mechanisms of pediatric Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis (EBV‐HLH), where EBV infection triggers a cytokine storm leading to immune cell hyperactivation and tissue damage. Dynamic plasma biomarkers (EBV‐DNA, ferritin, and interferon‐γ) effectively predict treatment response ...
Liu F, Zhang Q, Chen S, Zhao Y, Wang D, Lian H, Ma H, Wang T, Zhang R, Li Z.   +9 more
europepmc   +2 more sources

Epstein-Barr Virus

Microbiology Spectrum, 2016
ABSTRACT This review covers relevant clinical and laboratory information relating to Epstein-Barr virus (EBV) infections in immunocompromised hosts. It describes the epidemiology and clinical manifestations with a primary focus on disease in solid organ and stem cell transplant recipients.
Andrew, Nowalk, Michael, Green
openaire   +2 more sources

Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy. [PDF]

, 2007
Epstein-Barr virus (EBV) is associated with a number of human malignancies. EBV-positive post-transplant lymphoproliferative disease in solid organ and hematopoietic stem cell transplant recipients has been successfully treated by the adoptive transfer ...
Burdach, S., Witter, K., Boerschmann Heike, Boerschmann, H., Mautner, Josef, Georg W Bornkamm, Adhikary, D., Adhikary, Dinesh, Uta Behrends, Burdach Stefan, Bornkamm, G.W., Mautner, J., Georg W, Andrea Pfünder, Moosmann, A., Witter Klaus, Adhikary Dinesh, Pfünder, Andrea, Dinesh Adhikary, Klaus Witter, Pfünder Andrea, Josef Mautner, Behrends Uta, Stefan Burdach, Moosmann Andreas, Andreas Moosmann, Bornkamm Georg W., Behrends, Uta, Boerschmann, Heike, Burdach, Stefan, Bornkamm, Georg W., Pfünder, A., Witter, Klaus, Behrends, U., Mautner Josef, Moosmann, Andreas, Heike Boerschmann   +36 more
core   +1 more source

Epstein-Barr Virus LF2: an Antagonist to Type 1 Interferon [PDF]

, 2009
Upon viral infection, the major defense mounted by the host immune system is activation of the interferon (IFN)-mediated antiviral pathway, which is mediated by IFN regulatory factors (IRFs).
Shin, Young Chul, Johannsen, Eric, Haas, Juergen, Hyun Joo, Chul, Fossum, Even, Hutt-Fletcher, Lindsay M., Wu, L., Inn, Kyung-Soo, Jung, Jae U.   +8 more
core   +1 more source

Epstein-Barr Virus and the Eye [PDF]

Ocular Immunology and Inflammation, 2020
Epstein-Barr Virus (EBV), also known as Human HerpesVirus-4 (HHV-4), is a γ-type herpesvirus with a global infection prevalence of over 95%.1,2 Infection, which occurs nasopharyngeally via either a...
Emmett T, Cunningham, Manfred, Zierhut
openaire   +2 more sources

Relationship Between Non-Hodgkin's Lymphoma and Blood Levels of Epstein-Barr Virus in Children in North-Western Tanzania: A Case Control Study. [PDF]

, 2013
Non-Hodgkin's Lymphomas (NHL) are common in African children, with endemic Burkitt's lymphoma (BL) being the most common subtype. While the role of Epstein-Barr Virus (EBV) in endemic BL is known, no data are available about clinical presentations of NHL
Rambau, Peter, Kamugisha, Erasmus, Nestory Masalu, Maria Raffaella Petrara, Peter Rambau, Petrara Maria, Kamugisha Erasmus, De Rossi Anita, Kidenya Benson, De Rossi, Anita, Kabyemera R., Anita De Rossi, Masalu N., Kamugisha E., Kidenya, Benson, Benson Kidenya, Mwizamholya D., Damas Mwizamuholya, Petrara, Maria Raffaella, Rambau Peter, Mwizamuholya, Damas, Erasmus Kamugisha, Rambau P., Masalu Nestory, Rogatus Kabyemera, Masalu, Nestory, Kabyemera Rogatus, Mwizamuholya Damas, Maria Petrara, Kabyemera, Rogatus, Kidenya B.   +30 more
core   +2 more sources